The c-kit receptor tyrosine kinase (KIT) is activated upon ligand binding, thereby leading t o a variety of signaling events that play a fundamental role in hematopoiesis. In addition t o ligand-dependent activation, we have previously shown that KIT is constitutively activated in a ligand-independent manner by two point mutations, Val-559 --t Gly (G5591 mutation in the juxtamembrane domain and Asp-814 + Val (V8141 mutation in the phosphotransferase domain. To investigate the biochemical consequence and biologic significance of these mutations, retroviral vectors encoding KIPs9 or KITV8" were introduced into murine pro-B-type Ba/F3 cells and myeloid FDC-P1 cells, both of which require interleukin-3 (IL-3) for their growth and survival. In the cells, or KITV814 were found t o be constitutively phophorylated on tyrosine in the absence of stem cell factor (SCF) that is a ligand for KIT. Chemical cross-linking analysis showed that a substantial fraction of the phosphorylated KITG559 underwent dimerization even in the absence of SCF, HE PROTO-ONCOGENE c-kit is allelic with the white spotting (W) locus on mouse chromosome S,'.2 and it encodes a receptor tyrosine kinase (RTK) that is a member of the same RTK subfamily (type I11 RTK) as the receptors for platelet-derived growth factor and colony-stimulating factor 1 (CSF-1). 3 .4 This RTK subfamily is characterized by the presence of five Ig-like repeats in the extracellular domain and an insert that splits the cytoplasmic kinase domain into an adenosine triphosphate (ATP)-binding region and the phosphotransferase d~m a i n . "~ The ligand for c-kit product has been genetically mapped at the steel (Sl) locus on mouse chromosome 10, and is variously designated as stem cell factor (SCF), mast cell growth factor, kit ligand, or steel factor.'-' ' Binding of SCF to c-kit receptor tyrosine kinase (KIT) triggers a series of rapid events, including KIT dimerization and activation, association of KIT with certain cytoplasmic enzymes, and phosphorylation of other cellular proteins, thereby initiating a signaling cascade that leads to various cellular response^.^^^^^^-^' This KIT-mediated signal transduc-T whereas the phosphorylated KITV814 did not, suggesting the distinct mechanisms underlying constitutive activation of KIT by G559 and V814 mutations. Furthermore, the cells expressing either KIT0559 or KITV8" were found t o show a factor-independent growth, whereas the cells expressing wildtype KIT ( K I F ) proliferated in response t o SCF as well as IL-3. Moreover, subcutaneous injection of Ba/F3 cells expressing or KITV8" into nude mice resulted in production of large tumors at all sites of the injection within 2 weeks, and all nude mice quickly succumbed t o leukemia and died. These results suggest that, although the mechanisms underlying constitutive activation of or KITV814 may be different, both of the activating mutations have a function t o induce a factor-independent and tumorigenic phenotype. Also, the data of this study raise the possibility that the constitutively activating mutations of c-kit may play a causal role in development of hematologic malignancies. tion is known to play a crucial role in proliferation, differentiation, migration, and survival of hematopoietic stem cells, mast cells, neural crest-derived melanocytes and germ For example, dominant-negative or loss-of-function mutations at KITIW locus impair the receptor function and thereby give rise to hypoplastic anemia and a deletion of mast cells in hematopoietic s y~t e m .~,~~-*~ In addition to a fundamental role of KIT in hematopoiesis, KIT may potentially function as an oncogenic protein, because c-kit was originally defined as a cellular homologue of feline sarcoma virus kit).'.'^ Furthermore, activating mutations of other RTKs such as c-fms and c -e r b l 3 2 I n e~~.~"~~ have been shown to have transforming activity.
To test this possibility, we have previously examined the expression and state of tyrosine phosphorylation of KIT in a series of leukemia cells,'""' and have found that KIT is constitutively activated in a ligand-independent manner in a human mast-cell leukemia cell line, HMC-I." Sequencing analysis of c-kit gene in HMC-1 cells showed the previously unidentified two point mutations, the Val-560 --t Gly ( ( 3 6 0 ) mutation in the juxtamembrane domain and the Asp-816 + Val (V816) mutation in the phosphotransferase domain.3' Transfection of murine c-kitG'y~ss9'Gss9' mutants, corresponding to human c-kitGs'" or c-kit""'" genes, into a human embryonic kidney cell line (293T) resulted in a ligand-independent activation of KITGssy or suggesting the presence of two constitutively activating mutations in c-kit gene.j' In addition, we have recently found that both a murine mastocytoma cell line (P-815) and a rat mast cell leukemia cell line (RBL-2H3) carry constitutively activating mutations of c-kit gene in the same Asp codon in the phosphotransferase d~m a i n .~~.~~ These results suggested that the activating mutations of c-kit gene could be involved in some aspect of neoplastic transformation of KIT-positive hematopoietic cells, including mast cells. However, the biologic significance and biochemical consequence of these activating mutations have yet to be determined. or c-kjtVa-811"(VRi4) or KITVs14 with constitutive tyrosine kinase activity was found not only to abrogate IL-3 requirement of the cells, but also to cause them to become tumorigenic in nude mice. Furthermore, chemical cross-linking analysis showed that KITG559 was organized at the plasma membrane in a dimerized form, whereas KITV8l4 was not. Thus, the results of these studies provide new insight into potential role of the activating mutations of c-kit proto-oncogene in receptor activation and oncogenesis.
MATERIALS AND METHODS
Reagents. Recombinant murine (rm) SCF and IL-3 were generous gifts of Kirin Brewery CO Ltd (Tokyo, Japan). Antiphosphotyrosine a murine monoclonal antibody (MoAb) generated against phosphotyramine, was generously supplied by Dr B. Drucker (Oregon Health Science University, Portland, OR). Rat-antimouse c-kit MoAb (ACK2) and full length of murine c-kit cDNA were kindly donated from Dr S.-I. Nishikawa (Kyoto University, Kyoto, Japan)." Anti-c-kit polyclonal antibody against synthetic peptide of C-terminal of human KIT was purchased from Oncogene Science, Inc (New York, NY); this antibody was found to react with murine KIT as well as human KIT. G418 (geneticin) and Polybrene were purchased from Sigma Chemical CO (St Louis, MO), and chemical cross-linker BS3 from Pierce (Rockford, IL).
Cells and mice. Ba/F3,3s a murine IL-3-dependent pro-B lymphoid cell line, was cultured in RPM1 1640 medium (Nakarai tesque, Kyoto, Japan) supplemented with 10% fetal calf serum (FCS; Flow Lab, North Ryde, Australia) and d L -3 at the concentration of 10 ng/mL. FDC-P1,36 a murine IL-3-dependent myeloid cell line, was maintained in the Fischer's medium (GIBCO, Grand Island, NY) supplemented with 20% horse serum (GIBCO) in the presence of rmIL-3 (10 ng/mL). A helper virus-free packaging cell line,"' $2, was maintained in Dulbecco's modified essential medium (Nakarai tesque) supplemented with 10% FCS. SUSl-3T3, a fibroblast cell line derived from SVS1-mutant mice lacking in SCF expression, was established in our laboratory as described previo~sly.~~ BALB/c-nu/ nu (nude) mice were obtained from Nippon SLC (Shizuoka, Japan); all mice were female and were 8 weeks of age at the time of cell injection.
Construction and retroviral transfer of mutated c-kit gene. A retroviral vector pM5Gneo;' a derivative of myeloproliferative sarcoma virus (MPSV), was a kind gift from Dr W. Ostertag (Universitat Hamburg, Hamburg, Germany). The mutated murine c-kit genes encoding KIFss9 or KITV8I4 were constructed by site-directed mutagenesis as described p r e v i~u s l y .~~
The full length of wild-type (WT) or mutated c-kit cDNAs were inserted into the EcoRI site of pM5Gneo. Retroviral vector (pM5Gneo) alone or retroviral vectors containing c-kitw, c-kitGSs9 or c-kitV8I4 genes were transfected into packaging cell line ($2) by calcium phosphate method, and G418-resistant clones of each packaging cell line were isolated. The virus titer was determined by infecting SVSZ-3T3 fibroblasts with serial dilutions of retrovirus-containing supernatant from each clone and by counting the numbers of G418-resistant colonies. The resultant viruses were termed pM5Gne0, pM5Gneo-KITWT, pM5Gneo-KIFss9, and ~M~G~~O -K I T~"~, and had approximately comparable viral titers ranging from 2 to 5 X 10' colony-forming units/mL of supernatant. For gene transfer, BaF3 and FDC-P1 cells (2 x 10' celldeach cell line) were cocultured with the virus-producing packaging cells for 48 hours in the presence of rmIL-3 (10 ng/mL) and Polybrene (8 pg/mL). After infection, the cells expressing neomycinresistant gene were selected by cultivation in a medium containing G418 (0.6 mg/mL) and rmIL-3 (10 ng/mL).
Flow cytometry. The cells (5 X 10') were washed with phosphate-buffered saline (PBS) and resuspended in PBS containing 0.5% bovine serum albumin (BSA; Sigma Chemical CO, St Louis, MO) and 0.1% NaN3. Cells were incubated with rat antimurine c-kit MoAb (ACK2) or rat monoclonal IgGl control (Becton Dickinson, Mountain View, CA) at 4°C for 30 minutes, and then washed three times with the buffer. Cells were subsequently incubated with fluorescein-conjugated goat-antirat IgG antibody at 4°C for 30 minutes, and washed two times before analysis using a FACScan flow cytometer (Becton Dickinson).
Stimulation with factors and cell lysis. Exponentially growing cells were washed free of serum and growth factors and incubated in serum-free medium (Cosmedium 003; Cosmobio, Tokyo, Japan) for 12 hours at 37°C to factor-deprive the cells. The cells (lo7 cells suspended in 1 mL of Cosmedium 003) were exposed to SCF (100 ng/mL) at 37°C for 15 minutes. After stimulation with factors, cells were washed with cold PBS and lysed in lysis buffer (20 mmom Tris-HC1, pH 8.0, 137 mmom NaC1, 10% glycerol, 1% Nonidet P-40) containing protease and phosphatase inhibitors as described p r e v i o~s l y .~~~~~.~~.~~ In soluble material was removed by centrifugation at 10,000g for 15 minutes at 4°C.
Immunoprecipitation and immunoblotting. The procedures of immunoprecipitation, gel electrophoresis, and immunoblotting were performed according to the methods described p r e v i o u~l y .~~~~~~ Briefly, the lysates were precleared with protein-G Sepharose beads (Pharmacia AB, Uppsala, Sweden) for 2 hours at 4°C. The precleared lysates were incubated with ACK2 and protein-G Sepharose beads to collect antigen-antibody complexes. The immunoprecipitates were washed five times with lysis buffer containing protease and phosphatase inhibitors, and subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were electrophoretically transferred from the gel onto a polyvinylidene difluoride membrane (Immobilon, Millipore Corp, Bedford, MA). After blocking residual binding sites on the filter by incubation in TBS (10 mmollL Tris-HCI pH 8.0, 150 mmom NaCl) containing 1% gelatin (Bio-Rad Laboratories, Richmond, CA), immunoblotting was performed with an antiphosphotyrosine MoAb or anti-c-kit polyclonal antibody.
Chemical cross-linking experiments. Dimerization of KIT was analyzed by chemical cro~s-linking."~ Ba/F3 cells expressing KITWT, KITGss9 or KITV*l4 were washed twice and suspended in PBS containing 1 mg/mL BSA. The cells were stimulated with or without rmSCF (300 ng/mL) for 90 minutes at 4"C, and were washed five times in ice-cold PBS. The cells were then incubated in PBS containing 1 mmollL BS3 for 30 minutes at 22"C, and the reaction was terminated by washing in ice-cold PBS, followed by the incubation in 150 mmollL glycine-HC1 (pH 7.5) for 5 minutes at 4°C. In these buffers used after stimulation with or without rmSCF, sodium orthovanadate (Na3V04, 100 pmoVL) was included to prevent dephosphorylation of KIT. The cells were lysed in lysis buffer, and immunoprecipitations were performed with anti-c-kit polyclonal antibody as described above. For the detection of KIT that was phosphorylated on tyrosine, KIT-containing immunoprecipitates were subjected to SDS-PAGE (4% acrylamide) and immunoblotting with an antiphosphotyrosine MoAb and developed with horseradish-peroxidase-conjugated antimouse IgG (Promega, Madison, WI) and chemiluminescence reagent (Renaissance; DuPont, Boston, MA).
Cellproliferation assay. To quantitate cell proliferation, we used an M T I [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, Sigma] rapid colorimetric assay as previously de~cribed.~'.~' Briefly, quadruplicate aliquots of cells (1 X IO4 Ba/F3 cells or 2 x lo4 FDC-PI cells suspended in 100 pL of the medium supplemented For personal use only. on October 23, 2017. by guest www.bloodjournal.org From with 10% FCS) were cultured in 96-well microtiter plates for 72 hours at 37°C in the presence or absence of various concentrations of mSCF or rmLL-3. M l T (10 pL of 5 mg/mL solution of M'IT in PBS) was added to all wells for the final 4 hours of culture. Acid isopropanol (100 pL of 0.04 N HCl in isopropanol) was added to all wells, and mixed thoroughly to dissolve the dark blue crystals. The optical density (OD) was then measured on a Microelisa plate reader (Corona Electric CO, Ibaragi, Japan) with a test wavelength of 540 nm and a reference wavelength of 620 m. This assay was found to give equivalent results obtained by 3H-thymidine incorporation or cell enumeration as described p r e v i o~s l y .~~*~'~~~ or K I T V s l 4 were washed and resuspended in serum-free RPMI-1640 media. In addition, Ba/F3 cells transfected with pM5Gneo were used as a negative control. Cells (3 X lo6 injected site; two sites per mouse) were subcutaneously injected into the posterior flank of nude mice that had received 2.5 Gy (250 rads) of x-ray irradiation 1 day before the injection. Mice were carefully monitored for their signs of palpable or visible tumors at the sites of injection. The tumor tissues were fixed by 10% formamide overnight and embedded in paraffin. The sections (4-pm thick) were histopathologically analyzed after staining with hematoxylin and eosin.
Tumorigenicity assay. BaR3 cells expressing KITw,
RESULTS
Retroviral transfer of wild-type and mutant KIT into murine IL-3-dependent cell lines. To investigate the role of constitutively activating mutations of c-kit proto-oncogene in factor-independent growth and tumorigenicity, we infected two murine IL-3-dependent cell lines, B e 3 (pro-B type) and FDC-P1 (myeloid type), with replication-defective retroviruses containing c-kitw, c-kitGSs9 or c-kitV8l4 genes, which were termed pM5Gneo-KITw, pM5Gneo-KI'F9 or pM5Gneo-KITVSL4, respectively ( Fig 1A) . As a control, viruses carrying pM5Gneo retroviral vector alone (pM5Gneo) were infected into the cells. After selection in a G418-containing medium for 2 weeks, surface expression of KIT on the infected cells was examined with a rat antimouse c-kit MoAb ACK2, which recognizes the extracellular domain of murine KIT. Flow cytometric analysis showed that, although infection of B e 3 cells with pM5Gneo vector alone (BaF43-Vector) resulted in no expression of KIT, BalF3 cells infected with pM5Gneo-KITw (BaF3-KITw) or pM5Gneo-KIFs59 (BaF3-KIFss9) showed abundant surface expression of KITw or mss9 on their surface, respectively (Fig 1B) .
In the cells infected with ~M S G~~O -K I T~"~ (BaF3-KITV8l4), surface expression of KITV814 was also detectable, albeit to a lesser degree (Fig 1B) . Similar results were obtained from flow cytometric analyses of FDC-P1 cells infected with pM5Gne0, pM5Gneo-KITw, ~M~G~~O -K I~~~~, or ~M S G~~O -K I T~~~~ (Fig 1B) : FDC-P1 cells infected with pM5Gneo-KITw (FDCP1-KITWT) or pM5Gneo-KITGSs9 (FDCP1-KITG559) exhibited high levels of KITw or KIPss9 expression; the cells infected with pM5Gneo-KITV8I4 (FDCPi-KITv8") did moderate KITV8I4 expression; and little expression of KIT was observed on the cells infected with pM5Gneo (FDCP1-Vector).
Constitutive tyrosine phosphorylation of mutant KIT in factor-dependent cell lines. To examine the state of KITtyrosyl phosphorylation in the infected cells, the cells were deprived of serum and growth factors for 12 hours and stimulated with or without rmSCF (100 ng/mL) for 15 minutes. KIT was then immunoprecipitated and assayed by immunoblotting with either antiphosphotyrosine MoAb or antic-kit polyclonal antibody. As shown in Fig 2 (lower panel) , all of KITw, and KITV8I4 were found to be composed of 145-kD (mature) and 125-kD (immature) forms of KIT protein in the infected BalF3 cells. Immunoblotting with an antiphosphotyrosine MoAb showed that increased phosphotyrosine was observed in WWT, particularly in the 145-kD form of KITw, after treatment with rmSCF (Fig 2, upper   panel) . By contrast, both 145-kD and 125-kD forms of KIFss9 or KITV8I4 were strikingly phosphorylated on tyrosine regardless of m S C F stimulation (Fig 2, upper panel showed ligand-independent, constitutive tyrosine phosphorylation (data not shown).
Dimerization of KIT. All of RTKs have been shown to undergo ligand-dependent dimerization that plays an important role in activation of the intrinsic protein kinase activit^.'.^ To determine if the activating mutations of c-kit led to receptor dimerization regardless of stimulation with SCF, we performed cross-linking analysis of wild-type and mutant KIT (Fig 3) . BalF3 cells expressing KITw, KIF"' , or were stimulated with or without rmSCF (300 ng/ mL) and treated with the water-soluble cross-linker BS' that hardly enters the cytosol. Lysates for the cells were then immunoprecipitated with anti-c-kit polyclonal antibody and were subjected to immunoblotting with antiphosphotyrosine MoAb. As expected, rmSCF induced tyrosine phosphorylation of KITw in BaF3-KITw cells, and the phosphorylated form of KITw was detected in proteins at an approximate molecular mass of 330 kD that represented a cross-linked dimer of KITw and rmSCF ( K I T w /~S C F ) (Fig 3, left  panel) . By contrast, a substantial fraction of tyrosine-phosphorylated KIF5s9 was detectable in an -290-kD homodimeric form even in the absence of rmSCF, although tyrosine phosphorylation of dimerized KIF'"/I~SCF (-330 kD) was slightly intensified by the treatment with rmSCF (Fig  3, middle panel) . Notably, KITVX1' was barely detectable in a -290-kD dimeric form without the addition of rmSCF, whereas an -330-kD cross-linked form of KITV*"/rmSCF was observed after stimulation with rmSCF (Fig 3, right  panel) . These results suggest that G559 mutation may result in dimerization of K P s s 9 , whereas V814 mutation may not induce receptor association at least in the extracellular domain.
Role of constitutively activating mutations in factor-independent growth. To determine if KIFss9 and KITVRi4 could induce factor-independent growth, BalF3 and FDC-P1 cells expressing KITw, KIFss9, or KITVR1' were cultured in the presence of 0 to 10 ng/mL rmIL-3 or 0 to 500 ng/mL rmSCF for 72 hours, followed by measurement of cell proliferation using an M7T colorimetric assay (Fig 4) . As was the case for each parental cell line,gs.gh rmIL-3 induced a dose-dependent ing either KITGss' or KITV8I4 proliferated in the absence of exogenous rmIL-3 or rmSCF; and rmIL-3 or rmSCF had a minimal effect on proliferation of the cells. To exclude the possibility that factor-independence could be caused by autocrine stimulation by IL-3 or SCF synthesized by the KITGss9, KITV*'4-expressing cells th'emselves, we assayed conditioned media from these cells for growth supporting activity. The conditioned media could not induce proliferation or survival of parental IL-3-dependent cell lines or SCF-responsive KITwT-positive lines (data not shown), suggesting ligandindependent growth of Ba/F3 and FDC-P1 cells by KITGss9
and KIT""'. Effects of wild-type and mutant KIT on tumorigenicity. To further analyze the malignant potential of the KIT-infected cell lines, each was inoculated subcutaneously into five nude mice (3 X lo6 cells/injected site; two sites/mouse). BaF3-vector cells that were used as a control did not yield any detectable tumors within the 6-week observation period (Table 1, Fig 5) . By contrast, both BaF3-KITGS5' and BaF3-KITV814 cells produced large tumors at all sites of inoculation within 10 days; and all nude mice quickly succumbed to leukemia and died within 2 to 3 weeks ( Table 1) . Furthermore, pathologic analysis of these mice showed massive infiltration of BaF3-KITGss9 and BaF3-KITV8'4 cells into bone marrow, spleen, and liver (Fig 5) . The tumor cells isolated from bone marrow and spleen were similar to the injected cells in the expression patterns of KIT and B-220 antigen, suggesting that the tumors were originated from the injected cells (data not shown). In the mice injected with BaF3-KITWT cells, no detectable tumors were noted within 2 weeks, but small nodules developed at 3 of 8 injection sites at day 21 (Table 1) . Tumors developed at only two thirds of the BaF3-KITWT-injected sites after an extended latency (3 to 6 weeks), and the mice were all alive within the 6-week observation period.
DISCUSSION
It is well established that a large number of structural alterations of KIT identified so far in mice, rats, and humans cause either the diminished levels of KIT expression or the qualitative defects in KIT tyrosine kinase activity, thereby leading to a decrease in tyrosine kinase activity of In addition to the loss-of-function mutations, we have recently provided evidence that KIT can be activated in a ligandindependent manner by two activating mutations resulting in intracellular amino acid substitutions of Gly-559 for Val and Val-814 for Asp." However, the importance of these activating mutations in cell transformation has not been clarified.
In this study, we have investigated the effects of these mutations on the state of KIT expression and also on the cell growth and tumorigenesis. The results show that G559 and V814 mutations of the c-kit proto-oncogene result not only in constitutive tyrosine phosphorylation of KIT proteins without the addition of exogenous ligand, but also in ligandindependent growth of IL-3-dependent murine hematopoietic cell lines, B e 3 and FDC-PI, at an almost similar level. In addition, both of these mutations were found to render Ba/F3 cells tumorigenic in nude mice. This almost equal ability of KITGss9 and KITVX14 to induce a factor-independent and tumorigenic phenotype was partially unexpected, be- For personal use only. on October 23, 2017. by guest www.bloodjournal.org From cause our previous study showed that KITVXl4 exhibited a significantly higher level of tyrosine phosphorylation and activation than in a transient expression system using 293T cells.32 However, the results of this study using a stable expression system suggest that both KITC'"' and KITV8" have potential to function as oncogenic proteins.
We also provide the data suggest that high or stable expression of KIT^^ may play a role in excessive proliferation or transformation of hematopoietic cells. Although proliferation of BaF3-KITW cells was not supported in vitro in the absence of IL-3 or SCF, the subcutaneous inoculation of BaF3-KITWT cells into nude mice was found to result in development of skin tumors, albeit to a much lesser degree than that of BaF3-KIPS5' or BaF3-KITVX" cells. Nude mice are known to lack T cells that are a major source of IL-3. but to exhibit normal number of mast cells in the connective tissue^^^^^' indicating the absence of IL-3, but the presence of SCF in nude mice. Therefore, it is suggested that the slow but detectable growth of BaF3-KITWT cells may be generated by their interaction with SCF that is presumably produced by certain mesenchymal cells as a membrane-bound or soluble form." Also, it is suggested that the enhanced expression of KITWT by itself is not sufficient to cause cell transformation, and the continuous stimulation of KITWT by ligand is necessary for exhibiting the transformed phenotype. Despite the dramatic effects of G559 and V814 mutations on the factor-independent and tumorigenic phenotypes, the precise mechanisms by which the c-kit mutations activate KIT tyrosine kinase and transmit oncogenic signals into cells are not completely understood. Although some evidence has been presented that epidermal growth factor receptor can be activated through an intramolecular mechanism and does not necessarily require receptor dimerization,"',s" a large number of studies have suggested that receptor dimerization plays an essential role in the activation of intrinsic protein kinase activity and also in signal Furthermore, there is increasing evidence that the transphosphorylation between the dimerized receptor kinase domains can occur after ligand binding and the receptor cross-phosphorylation may underlie the natural mechanism of receptor activation.u.s'.s2 In this For personal use only. on October 23, 2017. by guest www.bloodjournal.org From study, we have found that a substantial fraction of exists as a dimerized form even in the absence of rmSCF. This result suggests that G559 mutation may yield receptor dimerization resulting in enzymatic activation that leads to cell transformation. This finding is comparable with the previous results showing that a point mutation of c-erbBlneu, in which glutamic acid substitute for valine at codon 664 in the transmembrane domain, leads to constitutive dimerization and activation of the tyrosine kinase recept0r.2~ In contrast to m559, cross-linking analysis using BS3 showed that a dimeric form of KITV814 was scarcely detectable in the absence of rmSCF, whereas a 3 3 0 -0 cross-linked form of the KITV8'4/rmSCF was observed after stimulation with rmSCF. Therefore, it is possible that V814 mutation may be a unique activating mutation that induces factor-independent growth and tumorigenesis independently of receptor dimerization. Also, despite little evidence for dimerization of RTK in the cytoplasmic domain, it is possible that association of receptor may be mediated by the cytoplasmic domain, thereby leading to receptor activation and cell transformation. The experiments to test these possibilities are currently underway.
In addition to KIT, constitutively activating point mutations have been found in hematopoietic growth factor receptors such as CSF-1 receptor (CSF-1R; the product of c-fis proto-on~ogene)~~,~~ and erythropoietin receptor ( E~o R ) ?~,~~ Activating mutations in CSF-1R were shown to induce morphologic transformation, anchorage-independent growth, and tumorigenicity in mouse NM3T3 activating mutations have been detected in a fraction of myelodysplastic syndrome and acute myelocytic leukemia.55 Furthermore, despite no kinase sequences in the cytoplasmic domain, activating mutations in EpoR were reported to initiate the development of erythroleukemia in murine experimental models.54 However, CSF-1 and Epo, respectively, are thought to act primarily on cells of monocyte/macrophage and erythroid lineages, and neither of them are very potent growth factors for hematopoietic stem ~e l l s .~~,~~ By contrast, KIT is known to express on various types of hematopoietic stedprogenitor cells as well as mast ce11s7.23,3y,58,59 and SCF acts as a potent mitogen to stimulate directly the growth of the cells particularly in combination with other growth factors like Epo, granulocyte-macrophage CSF, granulocyte CSF, IL-3, and mutations in KIT may contribute to aberrant cell growth and leukemogenesis of mast cells and various types of hematopoietic stemlprogenitor cells. This possibility may be supported, at least in part, by our recent findings that constitutively activating mutations of c-kit gene are detectable in the same Asp codon within the phosphotransferase domain in both a murine mastocytoma cell line (P-815) and a rat mast cell leukemia cell line (RBL-2H3).33*34 Also, the possibility may be additionally supported by our preliminary study showing that retroviral transfer of the c-kif mutant genes into normal hematopoietic stem cells results in formation of various types of colonies in the absence of hematopoietic growth factors.
In summary, the results presented here show that introduction of the c-kit mutant genes into IL-3-dependent cell lines 1~-7.7.Y.I3.l4.60.62 Therefore, it is possible that the activating results in production of a factor-independent and tumorigenic phenotype and suggest that the constitutively activating mutations of c-kit gene may be involved in some aspect of neoplastic transformation of hematopoietic cells. Identification of molecular mechanisms responsible for the receptor activation and signaling events of the KIT mutants will be important in understanding the role of KIT in normal and abnormal growth of hematopoietic cells.
